[Future Prospects of Anit-PD-1 or Anti-PD-L1 Antibody Therapy].
Junzo
J
Hamanishi
Masaki
M
Mandai
Ikuo
I
Konishi
D000906:Antibodies / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000276:immunology*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*; D012008:Recurrence; D015398:Signal Transduction / Q000187:drug effects
D000906:Antibodies; D060890:B7-H1 Antigen; C423236:CD274 protein, human; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor